Literature DB >> 16197452

Transcription repression activity is associated with the type I isoform of the MMSET gene involved in t(4;14) in multiple myeloma.

Katia Todoerti1, Domenica Ronchetti, Luca Agnelli, Stefano Castellani, Silvia Marelli, Giorgio Lambertenghi Deliliers, Alberto Zanella, Luigia Lombardi, Antonino Neri.   

Abstract

The WHSC1/MMSET gene, involved in t(4;14)(p16.3;q32) in multiple myeloma, encodes putative isoforms (MMSET I, MMSET II and RE-IIBP) which are thought to be involved in transcription regulation. We investigated their activity in transfected 293T and HeLa cells. Both MMSET I and MMSET II were localised in the nucleus, whereas RE-IIBP showed cytoplasmic and nucleolar staining. MMSET I dose-dependently repressed the transcriptional activity of the promoter region of the thymidine kinase gene, whereas MMSET II and RE-IIBP had no effect. The HDAC inhibitor, trichostatin A, reduced MMSET I repression activity and in vitro co-immunoprecipitation analyses indicated that MMSET I specifically recruits HDAC1 and mSin3b, but not HDAC2 or HDAC4. Our data support the hypothesis that MMSET may act as a transcription regulator; different functions may be associated with distinct isoforms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16197452     DOI: 10.1111/j.1365-2141.2005.05741.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  12 in total

1.  MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC.

Authors:  D-J Min; T Ezponda; M K Kim; C M Will; E Martinez-Garcia; R Popovic; V Basrur; K S Elenitoba-Johnson; J D Licht
Journal:  Leukemia       Date:  2012-09-13       Impact factor: 11.528

Review 2.  Future of Personalized Therapy Targeting Aberrant Signaling Pathways in Multiple Myeloma.

Authors:  Faiz Anwer; Kevin Mathew Gee; Ahmad Iftikhar; Mirza Baig; Atlantis Dawn Russ; Sabina Saeed; Muhammad Abu Zar; Faryal Razzaq; Jennifer Carew; Steffan Nawrocki; Hussam Al-Kateb; Nadia Nunes Cavalcante Parr; Ali McBride; Jason Valent; Christy Samaras
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2019-03-25

3.  Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway.

Authors:  Gouji Toyokawa; Hyun-Soo Cho; Ken Masuda; Yuka Yamane; Masanori Yoshimatsu; Shinya Hayami; Masashi Takawa; Yukiko Iwai; Yataro Daigo; Eiju Tsuchiya; Tatsuhiko Tsunoda; Helen I Field; John D Kelly; David E Neal; Yoshihiko Maehara; Bruce Aj Ponder; Yusuke Nakamura; Ryuji Hamamoto
Journal:  Neoplasia       Date:  2011-10       Impact factor: 5.715

4.  The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor.

Authors:  Jotin Marango; Manabu Shimoyama; Hitomi Nishio; Julia A Meyer; Dong-Joon Min; Andres Sirulnik; Yolanda Martinez-Martinez; Marta Chesi; P Leif Bergsagel; Ming-Ming Zhou; Samuel Waxman; Boris A Leibovitch; Martin J Walsh; Jonathan D Licht
Journal:  Blood       Date:  2007-12-21       Impact factor: 22.113

5.  Multiple-myeloma-related WHSC1/MMSET isoform RE-IIBP is a histone methyltransferase with transcriptional repression activity.

Authors:  Ji-Young Kim; Hae Jin Kee; Nak-Won Choe; Sung-Mi Kim; Gwang-Hyeon Eom; Hee Jo Baek; Hyun Kook; Hoon Kook; Sang-Beom Seo
Journal:  Mol Cell Biol       Date:  2008-01-02       Impact factor: 4.272

6.  The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity.

Authors:  Josh Lauring; Abde M Abukhdeir; Hiroyuki Konishi; Joseph P Garay; John P Gustin; Qiuju Wang; Robert J Arceci; William Matsui; Ben Ho Park
Journal:  Blood       Date:  2007-10-17       Impact factor: 22.113

7.  A novel functional role for MMSET in RNA processing based on the link between the REIIBP isoform and its interaction with the SMN complex.

Authors:  Fabio Mirabella; Alexander Murison; Lauren I Aronson; Christopher P Wardell; Andrew J Thompson; Sarah J Hanrahan; Jacqueline H L Fok; Charlotte Pawlyn; Martin F Kaiser; Brian A Walker; Faith E Davies; Gareth J Morgan
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

8.  H3K36 dimethylation by MMSET promotes classical non-homologous end-joining at unprotected telomeres.

Authors:  Inge de Krijger; Jaco van der Torre; Marieke H Peuscher; Mathias Eder; Jacqueline J L Jacobs
Journal:  Oncogene       Date:  2020-05-29       Impact factor: 9.867

9.  The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate.

Authors:  Yan Li; Patrick Trojer; Chong-Feng Xu; Peggie Cheung; Alex Kuo; William J Drury; Qi Qiao; Thomas A Neubert; Rui-Ming Xu; Or Gozani; Danny Reinberg
Journal:  J Biol Chem       Date:  2009-10-06       Impact factor: 5.157

Review 10.  MMSET: role and therapeutic opportunities in multiple myeloma.

Authors:  Zhigang Xie; Wee Joo Chng
Journal:  Biomed Res Int       Date:  2014-07-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.